Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Net Receivables
$3.49B
Quarterly · Period ending: · USD
TEVA Net Receivables
Latest reported$3.49Bperiod ending
Latest reported$3.49Bperiod ending
TEVA Quarterly Net Receivables ($36.00M → $3.49B)
Quarterly net receivables
High-resolution chart · PNG
TEVA net receivables history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Receivables (USD) |
|---|---|
| 756,819,000 | |
| 721,100,000 | |
| 680,818,000 | |
| 0 | |
| 592,621,000 | |
| 460,016,000 | |
| 464,602,000 | |
| 416,400,000 | |
| 365,100,000 | |
| 350,900,000 | |
| 373,800,000 | |
| 347,700,000 | |
| 279,600,000 | |
| 283,000,000 | |
| 307,700,000 | |
| 328,100,000 | |
| 204,200,000 | |
| 193,800,000 | |
| 132,600,000 | |
| 134,700,000 | |
| 122,600,000 | |
| 106,400,000 | |
| 86,700,000 | |
| 62,400,000 | |
| 36,000,000 |